Biotech

All Articles

AvenCell bags $112M to flip 'switchable' CAR-Ts in the medical clinic

.AvenCell Rehabs has actually protected $112 thousand in collection B funds as the Novo Holdings-bac...

China- based biotech plans ph. 3 after observing midstage eye records

.China-based Minghui Pharmaceutical has connected its own thyroid eye condition treatment to a reduc...

Sangamo slashes opportunity to market for Fabry gene treatment as FDA consents to sped up approval deal

.Sangamo Therapies has actually pinpointed a quick way to market for its Fabry ailment applicant, li...

Otsuka's kidney health condition medicine strengthens UPCR levels in ph. 3 trial

.Otsuka Drug's kidney ailment drug has reached the key endpoint of a period 3 test through demonstra...

Roche tosses out $120M tau prospect, coming back rights to UCB

.Roche has come back the rights to UCB's anti-tau antitoxin bepranemab, leaving a $120 million bank ...

Editas reinforces in vivo approach through $238M Genenvant contract

.Editas Medicines has signed a $238 thousand biobucks deal to integrate Genevant Science's fat nanop...

Combo end results, Vicodin skip and outstanding safety and security

.Vertex has actually stated period 3 information on its own near-approval discomfort medicine candid...

Angelini pens $360M biobucks treaty for ph. 1 brain disorder medicine

.Italy's Angelini Pharma has authorized a $360 thousand biobucks contract fixated a stage 1-stage mi...

Sage lays off one-half of R&ampD team as well as shocks C-suite once again

.Sage Therapies' newest try to diminish its own pipe as well as staff are going to view a third of t...

With stage 1 record, Feeling has an eye on early-stage bladder cancer

.With its own lead applicant in a phase 3 trial for an uncommon eye cancer cells, Aura Biosciences i...